591 POSTER Antitumor activity of PLX4032, a selective V600EB-Raf inhibitor, as monotherapy and in combination with capecitabine ± bevacizumab in a colorectal cancer xenograft model
K. Kolinsky, G. Bollag, R. Lee, K. Packman, D. Heimbrook, F. Su, B. HigginsVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72525-4
File:
PDF, 60 KB
english, 2008